Denmark
Tuberculosis profile
Population  2012 5.6 million
Estimates of TB burden * 2012 Number (thousands) Rate
(per 100 000 population)
Mortality (excludes HIV+TB) 0.022 (0.021–0.023) 0.4 (0.38–0.42)
Mortality (HIV+TB only) <0.01 (<0.01–<0.01) 0.01 (0.01–0.02)
Prevalence  (includes HIV+TB) 0.56 (0.24–1) 10 (4.2–18)
Incidence  (includes HIV+TB) 0.41 (0.36–0.47) 7.4 (6.5–8.4)
Incidence (HIV+TB only) <0.01 (<0.01–<0.01) 0.12 (0.11–0.14)
Case detection, all forms (%) 83 (73–94)    
TB case notifications 2012        
New cases   (%) Retreatment cases (%)
Smear-positive 107 (31) Relapse    
Smear-negative 151 (44) Treatment after failure    
Smear-unknown / not done 5 (1) Treatment after default    
Extrapulmonary 74 (22) Other 47 (100)
Other 5 (1)      
Total new 342   Total retreatment 47  
           
Other (history unknown) 0        
Total new and relapse 342   Total cases notified 389  
New cases Smear-positive Smear-negative/ unknown/
not done
Extrapulmonary
M:F ratio 3.1 1.7 1.0
Age < 15 3 13 1
Laboratories 2012
Is second-line drug susceptibility testing available? Yes, in country
Treatment success rate 2011 (%)        
New smear-positive and/or culture-positive 61   Is rifampicin used
throughout treatment for
new patients?
Yes
New smear-negative/extrapulmonary 69  
Retreatment 59  
TB/HIV 2012 Number (%)
TB patients with known HIV status    
HIV-positive TB patients    
HIV-positive TB patients on co-trimoxazole preventive therapy (CPT)    
HIV-positive TB patients on antiretroviral therapy (ART)    
HIV-positive people screened for TB    
HIV-positive people provided with IPT    
Estimates of MDR-TB burden 2012*   New   Retreatment
% of TB cases with MDR-TB 1.2 (0.24–3.4) 0 (0–23)
MDR-TB cases among notified pulmonary
TB cases
3 (1–9) 0 (0–11)
Reported cases of MDR-TB 2012 New Retreatment Total
Cases tested for MDR-TB 260 (98%) 38 (81%) 298
Laboratory-confirmed MDR-TB cases 1 0 1
Patients started on MDR-TB treatment     1
Financing TB control 2013
National TB programme budget (US$ millions)  
***
(Rate per 100 000 population per year)
Mortality graph
___ Mortality  (excludes HIV+TB)

(Rate per 100 000 population)
Prevalence graph
___ Prevalence

(Rate per 100 000 population per year)
Incidence graph
__ Notifications Incidence
___
___ Incidence (HIV+TB only)

Treatment success rate (%)
tx success graph
__ New smear-positive and/or culture-positive
__ New smear-negative/extrapulmonary __
Retreatment

(Number of patients)
CPT ART graph
__ HIV-positive TB patients
__ on CPT __ on ART

 
 Data are as reported to WHO. Estimates of TB and MDR-TB burden are produced by WHO in consultation with countries.
 * Ranges represent uncertainty intervals Generated: 2014-04-17 Data: www.who.int/tb/data